# Prevent Cardiac Surgery Associated AKI Trial

> **NCT06620523** · PHASE2 · RECRUITING · sponsor: **George Washington University** · enrollment: 242 (estimated)

## Conditions studied

- Renal Failure
- Coronary Artery Disease
- Surgery
- Surgery-Complications

## Interventions

- **DRUG:** CoQ10 1200 mg orally with Glutathione 1000 mg orally
- **DRUG:** Group B: Placebo CoQ10 orally and Placebo Glutathione orally

## Key facts

- **NCT ID:** NCT06620523
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-18
- **Primary completion:** 2027-06-17
- **Final completion:** 2028-06-17
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620523, "Prevent Cardiac Surgery Associated AKI Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06620523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*